Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Amer Alzahrani MD"'
Autor:
Amer Alzahrani MD RRT, Hadeel Alkofide Ph.D., Hala Joharji PharmD, Ghazwa B. Korayem PharmD, Sarah Aljohani PharmD, Hanan Alshareef PharmD, Mashael AlFaifi PharmD, Hassan Alalawi MBBS, Khalid Al Sulaiman BCCCP, BCNSP, MBA, FCCM
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
Objectives Bleeding remains a common complication post-thoracic surgery. Although intravenous tranexamic acid (TXA) has been shown to decrease blood loss, its use has been associated with adverse effects. Accordingly, topical TXA has been proposed as
Externí odkaz:
https://doaj.org/article/0c5594ece7524430b9752cd80aa94f80
Autor:
Khalid Al Sulaiman MBA, BCCCP, BCNSP, FCCM, Ohoud Aljuhani PharmD, Ghazwa B. Korayem PharmD, Lina I. Alnajjar PharmD, Ali F. Altebainawi PharmD, Mashael AlFaifi PharmD, Ramesh Vishwakarma PhD, Abeer A. Alenazi PharmD, Mai Alalawi PharmD, Abdulrahman Alissa PharmD, Yazed S. Alsowaida BSc, PharmD, Samiah Alsohimi PharmD, Alaa Almagthali PharmD, Saeed M. Alay PharmD, Noora Altaher PharmD, Mohammed G. Alamri PharmD, Dalal Alangari PharmD, Amer Alzahrani MD, Habeeb Ibrahim Abdul Razack MPharm, MSc CRRA, Jwael Alhamoud BSc, Abdulrahman Alshaya PharmD, Jawaher Gramish PharmD, Kholoud Al Aamer MSc, Alawi S. Alsaeedi MD, Ghassan Alghamdi MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
Doxycycline has revealed potential effects in animal studies to prevent thrombosis and reduce mortality. However, less is known about its antithrombotic role in patients with COVID-19. Our study aimed to evaluate doxycycline's impact on clinical outc
Externí odkaz:
https://doaj.org/article/4046974d424c4dd1974531ccae8abb83